Thyssenkrupp Nucera Ag & Co. Kgaa · XETR:NCH2

Thyssenkrupp Nucera Ag & Co. Kgaa — thyssenkrupp nucera — Q3 2022/23 Earnings Presentation

28 slides from Thyssenkrupp Nucera Ag & Co. Kgaa's earnings presentation, Aug 28, 2023

  1. Slide 1: Update on Recent Business Developments & Q3 2022/23 Financials

    Update on Recent Business Developments & Q3 2022/23 Financials August 28, 2023 1

  2. Slide 2: With you today

    With you today Dr. Werner Ponikwar (CEO) Dr. Arno Pfannschmidt (CFO) Dr. Hendrik Finger (Head of IR) 2 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 Financials | thyssenkrupp nucera

  3. Slide 3: Disclaimer

    Disclaimer This presentation has been prepared by thyssenkrupp nucera AG & Co. KGaA (“thyssenkrupp nucera”) and comprises the written materials/slides for a presentation concerning thyssenkrupp nucera. By attending this presentation and/or reviewing the slides you agree to be bound by the following

  4. Slide 4: Recap IPO: Listing at Deutsche Börse on July 7

    Recap IPO: Listing at Deutsche Börse on July 7 + 6.8% Share price development1 vs. offer price of 20€ 526mn € IPO primary proceeds for thyssenkrupp nucera Free Float Energy 17,96% Shareholder Solutions structure Company 6,00% 50,19% thyssenkrupp post-IPO2 25,85% De Nora 1 As of August 25, 2023. 2 Ba

  5. Slide 5: Q3 Highlights

    Q3 Highlights Continued dynamic growth in third quarter 2022/23 – organizational ramp-up and project execution going according to CA order intake plans >200mn € Strong orderbook momentum continues – Significant increase of order intake in Chlor-Alkali accompanied by signed contract with H2GS for one

  6. Slide 6: 1. Business update

    1. Business update 6 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 Financials | thyssenkrupp nucera

  7. Slide 7: Strong orderbook momentum continued for both gH2 and CA

    Strong orderbook momentum continued for both gH2 and CA Green H2 – AWE Chlor-Alkali Installation of >700 MW Retrofit of large-scale CA plant Signed one of the largest gH2 projects in Europe to Partnership with OxyChem to install next generation install > 700 MW of electrolysis capacity to fuel an eB

  8. Slide 8: Accelerating demand for large-scale gH2 electrolyzers fuels project pipeline

    Accelerating demand for large-scale gH2 electrolyzers fuels project pipeline – strongest market dynamics currently seen in North America as of as of as of as of as of as of Aug 22 May 23 Aug 23 Aug 22 May 23 Aug 23 Potential No. of projects #97  #101  #103 contract value >17 €bn  ~19 €bn  >21 €b

  9. Slide 9: Accelerating organizational ramp-up in line with growth strategy

    Accelerating organizational ramp-up in line with growth strategy Operations Organization ESG-related topics • Strengthening of supply chain and expansion • Headcount increased further (to 628 • Setup of a central ESG steering and of manufacturing capacities to 5 GW employees per end of June) in orde

  10. Slide 10: 2. Update on Q3 22/23 financials & Q4 outlook

    2. Update on Q3 22/23 financials & Q4 outlook 10 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 Financials | thyssenkrupp nucera

  11. Slide 11: Dynamic top-line development continues in Q3

    Dynamic top-line development continues in Q3 - organizational and supply chain ramp-up accelerating Order backlog: Increase in CA due to new build orders in the Americas – AWE in line with ongoing project execution slightly below PY – significant order intake from H2GS still to come Sales: Group gre

  12. Slide 12: Q3 shows increased order intake, 9M below record-breaking PY

    Q3 shows increased order intake, 9M below record-breaking PY Order intake (mn €) Order Intake Q3 Q3 9M • AWE order intake mainly driven by first phase of H2GS project +13% -56% • CA order intake driven by strong new build business in North and 1.218 South America 290 vs. 304mn € Order Intake 9M in 9

  13. Slide 13: Positive top-line performance due to strong growth in AWE business

    Positive top-line performance due to strong growth in AWE business Sales (mn €) Sales development Q3 Q3 9M • AWE increased 11x and for the 1st time exceeds the 100 million +90% +79% euro mark per quarter • Continuous ramp-up in line with 493 expectations driven by Shell and NEOM project 254 • In CA

  14. Slide 14: Earnings growth in absolute terms despite accelerating ramp-up costs

    Earnings growth in absolute terms despite accelerating ramp-up costs EBIT (mn €) % of sales EBIT development Q3 Q3 9M • Increase in absolute EBIT driven by volume effects, which were +3mn € +9mn € partially compensated by higher ramp-up costs 20 EBIT development 9M • Increase in absolute EBIT driven

  15. Slide 15: Solid balance sheet will be further scaled up by IPO Proceeds

    Solid balance sheet will be further scaled up by IPO Proceeds Capital structure as of June 30, 2023 (mn €) Cash and cash Financial debt1 Accrued Net cash IPO primary Net cash plus equivalents pension and proceeds primary • Strong and well capitalised similar [will be visible proceeds balance sheet d

  16. Slide 16: How we see Q4 2022/23

    How we see Q4 2022/23 Sales EBIT • Expectation: Continuation of strong sales • Expectation: Negative EBIT margin in Q4, growth against previous year cumulative FY 2022/23 with positive EBIT contribution • Main driver: ongoing execution of significant AWE order backlog • Main driver: Continued organi

  17. Slide 17: We implement our growth strategy and confirm our mid- and long-term ambition

    We implement our growth strategy and confirm our mid- and long- term ambition Published May 15, 2023 Dynamic sales growth Consistent and profitable project execution Well on track to reach AWE EBIT and FCF break-even targets 17 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 F

  18. Slide 18: Key messages | Q3 2022/23 showed again strong momentum

    Key messages | Q3 2022/23 showed again strong momentum and ability to win in gH2 High, above-market sales growth, reflected in an 11-fold increase in gH2 sales and supported by a significant order backlog Strong CA business generated growing order intake while AWE business continues to expand succes

  19. Slide 19: Questions & Answers

    Questions & Answers 19 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 Financials | thyssenkrupp nucera

  20. Slide 20: Events & Financial Calendar

    Events & Financial Calendar Upcoming events Financial calendar IR Contact Sep 9 CoBa & ODDO Corporate Dec 18 FY 2022/23 thyssenkrupp nucera AG & Co. KGaA Conference (Frankfurt) Investor Relations Sep 12 Virtual Roundtable (AlsterResearch) +49 231 229 724 347 Sep 20 12th German Corporate ir@thyssenkr

  21. Slide 21: Appendix

    Appendix 21 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 Financials | thyssenkrupp nucera

  22. Slide 22: Group | Summary income statement Q3

    Group | Summary income statement Q3 (in mn €) Q3 21/22 Q3 22/23 Sales 98.7 187.5 % growth 7% 90% Cost of sales -80.0 -161.4 Gross margin 18.7 26.1 % margin 18.9% 13.9% R&D -3.9 -5.1 SG&A -10.5 -14.9 Other income /(expense), net 0.2 0.9 EBIT 4.4 7.0 % margin 4.4% 3.7% Financial income /(expense), net

  23. Slide 23: Group | Summary income statement 9M

    Group | Summary income statement 9M (in mn €) 9M 21/22 9M 22/23 Sales 275.0 493.4 % growth 25% 79% Cost of sales -221.9 -420.4 Gross margin 53.1 73.1 % margin 19.3% 14.8% R&D -10.7 -12.7 SG&A -30.1 -39.6 Other income /(expense), net -0.9 -0.5 EBIT 11.4 20.3 % margin 4.2% 4.1% Financial income /(expe

  24. Slide 24: Group | Summary balance sheet assets

    Group | Summary balance sheet assets (in mn €) Sept 30, 2022 June 30, 2023 Property, plant and equipment 8.4 9.4 Goodwill 57.4 54.6 Intangible assets other than goodwill 0.9 0.6 Other non-current assets1 12.5 16.2 Total non-current assets 79.2 80.7 Inventories 77.3 89.0 Trade accounts receivable 35.

  25. Slide 25: Group | Summary balance sheet equity and liabilities

    Group | Summary balance sheet equity and liabilities (in mn €) Sept 30, 2022 June 30, 2023 Equity attributable to equity holders 211.4 221.0 Accrued pension and similar obligations1 7.0 7.4 Other provisions 1.8 1.3 Deferred tax liabilities 7.4 9.3 Lease liabilities 1.8 2.2 Total non-current liabilit

  26. Slide 26: Group | Summary cash flow statement

    Group | Summary cash flow statement (in mn €) 9M 21/22 9M 22/23 Net income 7.2 18.2 Depreciation & amortisation 2.5 3.3 Change in NWC1 71.4 -17.2 Other operating cash flow2 -2.1 -2.2 Operating cash flow 79.0 2.1 Capital expenditures -0.4 -1.3 Proceeds from disposals 0.2 0.1 Cashpool withdrawals/(dep

  27. Slide 27: We shape the new era.

    thyssenkrupp nucera the new era.

  28. Slide 28: 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 Financials |

    28 28 August 2023 | Update on Recent Business Developments and Q3 2022/23 Financials | thyssenkrupp nucera

thyssenkrupp nucera — Q3 2022/23 Earnings Presentation on 6ix